SUMAVEL DOSEPRO (sumatriptan succinate) Endo ventures ltd Patent: 8,491,524 Expiration: Nov 21, 2022 See More … For more information on […]
Drug Patent Expirations for the Week of November 20, 2022 Read Post »
Annual Drug Patent Expirations for SUMAVEL+DOSEPRO Sumavel Dosepro is a drug marketed by Endo Ventures Ltd and is included in
New patent expiration for Endo Ventures drug SUMAVEL DOSEPRO Read Post »
Annual Drug Patent Expirations for INBRIJA Inbrija is a drug marketed by Acorda and is included in one NDA. It
Annual Drug Patent Expirations for AMLODIPINE+BESYLATE Amlodipine Besylate is a drug marketed by Synthon Pharms, Accord Hlthcare, Alkem, Amneal Pharms
New patent expiration for Synthon Pharms drug AMLODIPINE BESYLATE Read Post »
Annual Drug Patent Expirations for VEREGEN Veregen is a drug marketed by Ani Pharms and is included in one NDA.
New patent expiration for Ani Pharms drug VEREGEN Read Post »
Annual Drug Patent Expirations for XOFIGO Xofigo is a drug marketed by Bayer Hlthcare and is included in one NDA.
New patent expiration for Bayer Hlthcare drug XOFIGO Read Post »
Annual Drug Patent Expirations for OCALIVA Ocaliva is a drug marketed by Intercept Pharms Inc and is included in one
New patent expiration for Intercept Pharms drug OCALIVA Read Post »
OCALIVA (obeticholic acid) Intercept pharms inc Patent: 7,138,390 Expiration: Nov 16, 2022 See More … For more information on how
Drug Patent Expirations for the Week of November 13, 2022 Read Post »
Annual Drug Patent Expirations for AMITIZA Amitiza is a drug marketed by Sucampo Pharma Llc and is included in one
New patent expiration for Sucampo Pharma drug AMITIZA Read Post »
Get fresh news and insights, drug patent expirations & more…
